Test Price
2,200 AED✅ Home Collection Available
Hemophilia A Common Mutation Screening (Factor VIII Intron 22 & Intron 1 Inversion Analysis) – 2,200 AED – DHA Licensed
Executive Summary & Core Metrics
- DHA Facility License Number: 1143
- Lab: DNA Labs UAE
- Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
- Test Price: 2,200 AED
- 99.9% Diagnostic Sensitivity – ISO-accredited Gap‑PCR (End‑Point PCR) with dual‑target inversion analysis
- VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection – Available 8 AM – 11 PM, with ISO‑certified transport
- Post‑Test Clinical Guidance – Complimentary telephonic result interpretation by DHA‑licensed clinical specialists
- Insurance Direct Billing Verification – WhatsApp us at +971 54 548 8731
- Prescription Required – A valid physician referral is mandatory unless for pre‑surgical clearance, pregnancy‑related screening, or international travel requirements
This test is performed in compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the use of information and communication technology in health fields.
Test Overview & Methodology
Hemophilia A is an X‑linked bleeding disorder caused by inversions in the Factor VIII (F8) gene. This screening specifically detects the two most prevalent mutations – intron 22 and intron 1 inversions – using Gap‑PCR (End‑Point PCR), providing definitive molecular confirmation for affected individuals and carriers.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% sensitivity for intron 22 & 1 inversions | Conventional long‑range PCR (may miss inversions) |
| Method | Gap‑PCR (End‑Point PCR) – ISO 9001:2015 accredited | Southern blot (obsolete, slower, less sensitive) |
| Turnaround | 10–11 days with telephonic interpretation | 14–21 days without clinical guidance |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics (DHA registration ID: 9294403), I emphasize that a negative result does not rule out hemophilia A; about 50% of mutations are inversion‑independent. Clinical correlation with factor VIII activity, von Willebrand factor, and bleeding history remains essential. Please discuss any lifestyle or medication changes directly with your doctor.”
— Dr. Lina Osama Zaki Quteineh, DHA‑licensed Consultant Medical Genetics
Medication Warning
Do not discontinue prescribed anticoagulants, antiplatelets, or factor replacement therapy without consulting your treating physician. Abrupt cessation can trigger life‑threatening thrombosis or bleeding.
Exclusion Criteria & Emergency Red Flags
- Active, uncontrolled hemorrhage (e.g., intracranial, gastrointestinal) – seek immediate emergency care.
- Severe anemia (Hb <7 g/dL) or hemodynamic instability.
- Recent major surgery or trauma with ongoing heparin therapy.
- Inability to provide informed consent (or parental consent for minors) as per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- If you experience sudden severe joint pain, swelling (hemarthrosis), or prolonged nosebleeds, contact ER immediately.
Patient FAQ & Clinical Guidance
How long does it take to get results, and can I receive them online?
Results are ready in 10–11 working days and delivered via secure encrypted portal and WhatsApp. This timeframe accounts for Gap‑PCR amplification, dual‑inversion confirmation, and clinical review. A DHA‑licensed specialist will call you to explain the findings.
Is a doctor’s prescription mandatory for this test?
A prescription from a licensed physician is required, except for pre‑surgical clearance, pregnancy‑related screening, or international travel requirements. Under UAE Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019, all genetic testing must be ordered through a clinician to ensure proper counseling.
Will my insurance cover this hereditary hemophilia screening?
Coverage varies by policy; our team can verify your plan instantly via WhatsApp before the draw. We handle direct billing with major UAE insurers, and the test is often covered when medically indicated (family history, bleeding diathesis). Contact +971 54 548 8731 with your insurance card.
UAE Regulatory & Data Privacy Adherence
We strictly adhere to the Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the use of information and communication technology in health fields. Your genetic information is encrypted, access‑controlled, and never shared without explicit consent. All test results are delivered via secure channels.
Clinical oversight is provided by our DHA‑licensed Consultant Medical Genetics, Dr. Lina Osama Zaki Quteineh (DHA ID: 9294403), ensuring compliance with Federal Decree‑Law No. 4 of 2016 on Medical Liability for informed consent and patient safety.
For any data privacy concerns, contact our Data Protection Officer at dpo@dnalabsuae.com or call +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | Hemophilia A Common Mutation Screening (F8 Intron 22 & Intron 1 Inversions) |
| Price (AED) | 2,200 AED |
| Turnaround Time | 10–11 working days |
| Sample Type / Matrix | Whole blood (EDTA) |
| Methodology Used | Gap‑PCR (End‑Point PCR) |
| ICD-10-CM Code | D66 (Hemophilia A) |
| LOINC Code | 49880-3 (F8 gene inversion analysis) |
| DHA Facility License & Laboratory Address Invariants | DHA License 1143 – DNA Labs UAE – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians